Clinical trial
Accuracy of Metagenomic Blood Sampling to Identify Pathogen in Infective Endocarditis Patients
NCT06309680 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Accuracy of Metagenomic Blood Sampling to Identify Pathogen in Infective Endocarditis Patients
- Lead sponsor
- Queen Mary University of London
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 24, 2023
- Completion date
- October 1, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infective endocarditis